Dearest @Buckland,In case you have forgotten, the whole point of...

Dearest @Buckland,

In case you have forgotten,

the whole point of pivoting to a human MND trial (led by the long and frustrating canine program, who's primary priority was to lead the difficult process of developing a useful pill FOR HUMAN USE) was not only about treating human ALS/MND but to open up the door to general human use for neurological, cancer and virological uses.

And so impressed was the USA FDA with the early human ALS/MND trial results, that the FDA has granted PAA the highly coveted ODD - Orphan Drug Designation - for ALS/MND.

But the Buckybot says nothing to see here as the Buckybot must, always.


Cheerio